Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2023-08-30 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
2023年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "绿康生化股份有限公司2023 年半年度财务报告" which translates to "Lvkang Biochemical Co., Ltd. 2023 Semi-Annual Financial Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2023. The report explicitly states it is a half-year report and includes comprehensive financial data and analysis for the period. The document is about 15,000 characters long, which is substantial and contains the actual financial data rather than just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-30 Chinese
关于 2023 年半年度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the impairment provision for assets for the half-year period ending June 30, 2023. It includes details on the amount of impairment, the accounting standards followed, and the impact on the company's financials. The document is relatively short (1440 characters) and does not contain full financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report. Instead, it is a specific announcement about an accounting provision related to the half-year period. This type of announcement is best classified under Regulatory Filings (RNS) as it is a regulatory disclosure about an accounting matter rather than a full interim report or audit report.
2023-08-30 Chinese
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the 32nd meeting of the 4th Board of Directors of the company. It specifically mentions the approval of the company's 2023 semi-annual report (half-year report) by the board, but does not contain the report itself. It states that the full and summary semi-annual reports are available on external websites. The document is short (737 characters) and serves as a formal notice of the board meeting decisions rather than the actual financial report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the board meeting and report approval, not the report itself.
2023-08-30 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by independent directors regarding the company's related party fund occupation and external guarantees. It references regulatory guidelines and confirms the absence of related party fund occupation and illegal external guarantees during the reporting period. The document is a standalone audit-related statement focusing on compliance and internal checks rather than a full annual report or financial statement. It does not contain comprehensive financial data or results but provides an independent audit opinion on specific governance issues. Therefore, it fits best under Audit Report / Information (AR). The document length is short but contains substantive audit-related content, not merely an announcement or certification. H1 2023
2023-08-30 Chinese
半年报财务报表
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements including consolidated and standalone balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2023. The presence of comprehensive financial data for a six-month period indicates this is an interim or quarterly financial report. The document is about 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or certification. The title and content clearly indicate it is a semi-annual financial report for 2023, which fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-30 Chinese
关于公司向银行申请授信的进展暨申请并购贷并质押全资子公司股权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's progress in applying for bank credit and a loan for acquisition purposes, including pledging equity of a wholly-owned subsidiary. It details the board meeting approval, the loan amount, pledge details, and the expected impact on the company. There are no financial statements or detailed financial performance data included. The document is primarily about financing activities and credit application progress, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it is not merely announcing a report publication, so it is not RPA or RNS.
2023-08-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.